| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 08/20/2008 | CN101247853A Substituted indole compounds having NOS inhibitory activity |
| 08/20/2008 | CN101245062A Tetrahydroquinoline compound, preparation method and pharmaceutical composition |
| 08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 08/19/2008 | US7414132 prophylaxis and treatment of obesity; secondary amines such as 6-{4-[(3-Methyl-butylamino)-methyl]-phenoxy}-nicotinimidic acid ethyl ester |
| 08/19/2008 | US7414073 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |
| 08/19/2008 | US7414071 Such as 5-(3-(2S-(3R-hydroxy-4-(3-trifluoromethyl-phenyl)-butyl)-5-oxo-pyrrolidin-1 -yl)-propyl)-thiophene-2-carboxylic acid; prostaglandin E2 agonists subtypes (EP4); for treatment of (ocular) hypertension, liver failure, and glaucoma |
| 08/19/2008 | US7414070 Indol-7-YL sulfonamide derivatives, their preparation and their use in pharmaceutical compositions |
| 08/19/2008 | US7414065 Methods to modulate conditions mediated by the CXCR4 receptor |
| 08/19/2008 | US7414063 e.g. 2-(2-bromo-4-fluoro-phenoxy)-ethyl]-[2-(isoquinoline-5-sulfonylamino)-ethyl]-carbamic acid tert-butyl ester; serine/threonine kinase inhibitor; anticarcinogenic agent; solid tumor, leukemia |
| 08/19/2008 | US7414046 Gyrase inhibitors and uses thereof |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 08/19/2008 | CA2200871C Aniline derivatives |
| 08/14/2008 | WO2008097976A1 Heterocyclic modulators of tgr5 for treatment of disease |
| 08/14/2008 | WO2008097428A2 Compounds and compositions as modulators of gpr119 activity |
| 08/14/2008 | WO2008097235A1 Process for the oxidation of certain substituted sulfilimines to insecticidal sulfoximines |
| 08/14/2008 | WO2008096791A1 Acylguanidine derivative |
| 08/14/2008 | WO2008096746A1 Spiro compound and use thereof |
| 08/14/2008 | WO2008096739A1 Benzimidazole compound-containing composition and light-emitting device using the composition |
| 08/14/2008 | WO2008096127A2 Bicyclo[2.2.1]hept-7-ylamine derivatives and their use as m3 muscarinic receptor modulators |
| 08/14/2008 | WO2008095293A1 [1,2,3] triazolyl substituted coumarins as inhibitors of leukotriene biosynthesis |
| 08/14/2008 | WO2008095292A1 [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
| 08/14/2008 | US20080194878 2,7-Di(4,4,5,5-tetramethyl-1,3,2-dioxa-borolan-2-yl)-9,9'-bis(4-methoxymethyloxyphenyl)-9H-fluorene, for example; can be utilized as hole transport materials, hole injection materials or the like of organic electroluminescence devices, electrophotographic receptors |
| 08/14/2008 | US20080194635 Antiinflammatory agents; respiratory system disorders; cystic fibrosis; antihistamines; inflammatory bowel disorders; COPD; Crohn's disease; gastrointestinal disorders |
| 08/14/2008 | US20080194629 3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors |
| 08/14/2008 | US20080194625 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 08/14/2008 | US20080194607 Modulation of pathogenicity |
| 08/14/2008 | US20080194597 Platelet adp receptor inhibitors |
| 08/14/2008 | US20080194588 Modulation of pathogcnicity |
| 08/14/2008 | US20080194574 Pyrazine Derivatives As Effective Compounds Against Infectious Diseases |
| 08/14/2008 | US20080194569 Phthalazinones |
| 08/14/2008 | US20080194561 Compounds |
| 08/14/2008 | US20080194552 Aminopyrimidine Derivatives With Tie2 Inhibiting Activity |
| 08/14/2008 | US20080193799 Organic electroluminescence device |
| 08/14/2008 | CA2677995A1 Acylguanidine derivative |
| 08/14/2008 | CA2677263A1 Compounds and compositions as modulators of gpr119 activity |
| 08/14/2008 | CA2676700A1 Process for the oxidation of certain substituted sulfilimines to insecticidal sulfoximines |
| 08/14/2008 | CA2676498A1 [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
| 08/13/2008 | EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity |
| 08/13/2008 | EP1954682A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia |
| 08/13/2008 | EP1954678A1 Novel nk1 and nk2 antagonists |
| 08/13/2008 | EP1664023B1 Sustituted isoquinoline derivatives and methods of use |
| 08/13/2008 | EP1501803B1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/13/2008 | EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | EP1020445B1 Fused pyridine derivatives |
| 08/13/2008 | CN101243073A Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor |
| 08/13/2008 | CN101243072A Piperidine derivatives useful as histamine H3 antagonists |
| 08/13/2008 | CN101243071A Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 08/13/2008 | CN101243048A 1-acyldihydropyrazol derivatives |
| 08/13/2008 | CN101239976A Dithienylethene compounds containing naphthalimide unit |
| 08/13/2008 | CN101239971A Biphenyl derivatives |
| 08/13/2008 | CN101239970A Biphenyl derivatives |
| 08/13/2008 | CN101239969A Biphenyl derivatives |
| 08/13/2008 | CN101239968A Biphenyl derivatives |
| 08/13/2008 | CN101239955A Method for producing fungicide composition |
| 08/13/2008 | CN101239945A Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 08/13/2008 | CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 08/13/2008 | CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 08/13/2008 | CN100409844C Noval compound, its synthetizing process and therapeutic use |
| 08/12/2008 | US7411098 Aldol condensation of citral with acetone and subsequent hydrogenation; using tetrahydrogeranylacetone for preparing phytol, isophytol, tocopherol and/or tocopherol derivatives |
| 08/12/2008 | US7411076 such as 2-chloro-N-(7-hydroxy-2-oxo-2H-1-benzopyran-3-yl)benzamide, used for intensifying the effects of cancer therapy based on DNA injury; protein kinase inhibitors; side effect reduction |
| 08/12/2008 | US7411073 cyclopent[f]pyrazole derivatives; antiinflammatory agent; autoimmune diseases; side effect reduction, advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity or metabolism |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7410997 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs |
| 08/12/2008 | US7410982 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride |
| 08/12/2008 | US7410972 Compounds |
| 08/12/2008 | US7410970 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/12/2008 | US7410961 2,6-disubstituted piperiddines as modulators |
| 08/12/2008 | US7410933 Substituted thiene-3-ylsulphonylamino(thio)carbonyl-triazolin(thi)ones |
| 08/12/2008 | US7410777 Continously induced g-protein coupled receptors; membrane binding assays |
| 08/07/2008 | WO2008094992A2 2-aminopyridine derivatives useful as kinase inhibitors |
| 08/07/2008 | WO2008093065A1 L-ALANINE DERIVATIVES AS α5βL ANTAGONISTS |
| 08/07/2008 | WO2008092665A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| 08/07/2008 | WO2008074413A3 Heteroarylacrylamides and their use as pharmaceuticals for the stimulation of the expression of endothelial no synthase |
| 08/07/2008 | WO2008030266A3 Insecticidal n-substituted (heteroaryl)alkyl sulfilmines |
| 08/07/2008 | US20080188670 Mesogenic and high charge mobility; photoelectric conversion and electroluminescent devices |
| 08/07/2008 | US20080188536 2-thiophenecarboxylic acid-5-nitro-2-(2-thienylcarbonyl)hydrazide; antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial setting; bacterial damage or disease; Pseudomonas aeruginosa or Burkholderia cepacia |
| 08/07/2008 | US20080188535 2-thiophenecarboxylic acid-5-nitro-2-(2-thienylcarbonyl)hydrazide; antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial setting; bacterial damage or disease; Pseudomonas aeruginosa or Burkholderia cepacia |
| 08/07/2008 | US20080188527 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer |
| 08/07/2008 | US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 08/07/2008 | US20080188491 Modulation of pathogenicity |
| 08/07/2008 | US20080188485 4-piperazine-4-piperidine-1-ketone derivatives; graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 08/07/2008 | US20080188472 Indole-2-Carboxylic Acid Hydrazides |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | CA2677096A1 Kinase inhibitors |
| 08/07/2008 | CA2676291A1 Substituted gamma lactams as therapeutic agents |
| 08/07/2008 | CA2675466A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| 08/06/2008 | EP1953153A1 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
| 08/06/2008 | EP1953147A1 Heterocyclic compound and medicinal application thereof |
| 08/06/2008 | EP1953145A1 Heterocyclic compound having inhibitory activity on 11- -hydroxysteroid dehydrogenase type i |
| 08/06/2008 | EP1951842A1 Use of rylene derivatives as photosensitizers in solar cells |
| 08/06/2008 | EP1951717A1 Novel pyrrolidine derivatives as inhibitors of coagulation factor xa |
| 08/06/2008 | EP1951712A2 Chemical compounds |
| 08/06/2008 | EP1951707A1 Substituted pyrrolones as allosteric modulators of glucokinase |
| 08/06/2008 | EP1951706A1 Dihydroisoindolones as allosteric modulators of glucokinase |
| 08/06/2008 | EP1951689A1 P2x7 receptor antagonists and methods of use |
| 08/06/2008 | EP1951678A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| 08/06/2008 | EP1951676A2 Lxr modulators |
| 08/06/2008 | EP1951675A1 Tetrahydroisoquinoline as lxr modulators |